Every SEC Form 3/4/5 on record for this filer (CIK 1807133) — 1 issuer, 14 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Chief Commercial Officer | 2020-03-23 → 2025-02-11 | 16 | −$215,286 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PBYI | 2025-01-02 | Sell | 9,437 | $3.15 | $29,727 | 108,951 |
| PBYI | 2024-07-17 | Sell | 2,598 | $3.70 | $9,613 | 118,388 |
| PBYI | 2024-07-02 | Sell | 6,051 | $3.27 | $19,787 | 120,986 |
| PBYI | 2024-01-03 | Sell | 12,956 | $4.49 | $58,172 | 99,970 |
| PBYI | 2023-07-03 | Sell | 12,103 | $3.31 | $40,061 | 112,926 |
| PBYI | 2023-01-03 | Sell | 6,568 | $4.18 | $27,454 | 58,057 |
| PBYI | 2022-07-05 | Sell | 5,835 | $2.63 | $15,346 | 64,625 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.
